{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T02:30:02Z","timestamp":1770431402472,"version":"3.49.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.ejphar.2006.07.002","type":"journal-article","created":{"date-parts":[[2006,7,26]],"date-time":"2006-07-26T03:41:19Z","timestamp":1153885279000},"page":"125-135","source":"Crossref","is-referenced-by-count":30,"title":["Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma"],"prefix":"10.1016","volume":"547","author":[{"given":"Yang-mei","family":"Deng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang-min","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-fang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-gang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-fang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-qiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shui-you","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2006.07.002_bib63","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bcp.2004.09.012","article-title":"Dexamethasone down-regulates cAMP-phosphodiesterase in human osteosarcoma cells.","volume":"69","author":"Ahlstrom","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.07.002_bib1","doi-asserted-by":"crossref","first-page":"4864","DOI":"10.4049\/jimmunol.162.8.4864","article-title":"IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells","volume":"162","author":"Ahmad","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2006.07.002_bib2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/jlb.60.5.563","article-title":"Regulation of cytokine and cytokine receptor expression by glucocorticoids","volume":"60","author":"Almawi","year":"1996","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ejphar.2006.07.002_bib3","first-page":"1171","article-title":"Selective inhibition of purified human phosphodiesterase 4A expressed in yeast cell GL62 by ciclamilast, piclamilast and rolipram","volume":"25","author":"Chen","year":"2004","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2006.07.002_bib4","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1124\/jpet.103.064691","volume":"310","author":"Claveau","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2006.07.002_bib5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2133.1989.tb01344.x","article-title":"Peripheral blood mononuclear leukocyte cyclic adenosine monophosphate specific phosphodiesterase activity in childhood atopic dermatitis","volume":"120","author":"Coulson","year":"1989","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejphar.2006.07.002_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000024311","article-title":"Beclomethasone decreases elevations in phosphodiesterase activity in human T lymphocytes","volume":"121","author":"Crocker","year":"2000","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.ejphar.2006.07.002_bib8","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.4049\/jimmunol.172.11.7053","article-title":"Anti-inflammatory effects of mitogen-activated protein kinase inhibitor U0126 in an asthma mouse model","volume":"172","author":"Duan","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2006.07.002_bib10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2174\/1568010023344715","article-title":"Eotaxin receptor (CCR3) antagonism in asthma and allergic disease","volume":"1","author":"Erin","year":"2002","journal-title":"Curr. Drug. Targets Inflamm. Allergy"},{"key":"10.1016\/j.ejphar.2006.07.002_bib11","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/sj.bjp.0705892","article-title":"Effects of phosphodiesterase inhibitors on interleukin-4 and interleukin-13 generation from human basophils","volume":"142","author":"Eskandari","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.07.002_bib12","first-page":"1484","article-title":"In vitro down-regulation of antigen induced IL-5 gene expression and protein production by cAMP-specific phosphodiesterase type 4 inhibitor","volume":"278","author":"Foissier","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2006.07.002_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0079-6603(00)65001-8","article-title":"Cyclic nucleotide phosphodiesterases: relating structure and function","volume":"65","author":"Francis","year":"2001","journal-title":"Prog. Nucleic Acid Res. Mol. Biol."},{"key":"10.1016\/j.ejphar.2006.07.002_bib14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0091-6749(97)70146-5","article-title":"Phosphodiesterase profiles of highly purified human peripheral blood leukocyte populations from normal and atopic individuals, a comparative study","volume":"100","author":"Gantner","year":"1997","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2006.07.002_bib15","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1034\/j.1398-9995.2002.03555.x","article-title":"Eotaxin but not MCP-3 induces eosinophil influx into nasal fluid in allergic patients","volume":"57","author":"Gorski","year":"2002","journal-title":"Allergy"},{"key":"10.1016\/j.ejphar.2006.07.002_bib16","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0022-3565(24)37847-4","article-title":"SB 207499 (Ariflo), a second generation phosphodiesterase 4 inhibitor, reduces tumor necrosis factor \u03b1 and interleukin-4 production in vivo","volume":"287","author":"Griswold","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2006.07.002_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1046\/j.0022-0477.2001.01297.x","article-title":"The relationship between airway hyper-responsiveness, markers of inflammation and lung function depends on the duration of the asthmatic disease","volume":"32","author":"Gr\u00f6nke","year":"2002","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.ejphar.2006.07.002_bib18","doi-asserted-by":"crossref","first-page":"84S","DOI":"10.1111\/1523-1747.ep12316116","article-title":"Monocyte phosphodiesterase abnormalities and dysregulation of lymphocyte function in atopic dermatitis","volume":"105","author":"Hanifin","year":"1995","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejphar.2006.07.002_bib19","doi-asserted-by":"crossref","first-page":"6751","DOI":"10.1073\/pnas.97.12.6751","article-title":"Absence of muscarinic cholinergic airway responses in mice deficient in the cyclic nucleotide phosphodiesterase PDE4D","volume":"97","author":"Hansen","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2006.07.002_bib20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0022-3565(24)29537-9","article-title":"Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro","volume":"297","author":"Hatzelmann","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2006.07.002_bib21","doi-asserted-by":"crossref","first-page":"L1072","DOI":"10.1152\/ajplung.00076.2002","article-title":"An endothelin receptor antagonist, SB-217242, inhibits airway hyperresponsiveness in allergic mice","volume":"283","author":"Henry","year":"2002","journal-title":"Am. J. Physiol., Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.ejphar.2006.07.002_bib22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0091-6749(00)90066-6","article-title":"Epithelial-mesenchymal interactions in the pathogenesis of asthma","volume":"105","author":"Holgate","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2006.07.002_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20021698","article-title":"PDE4 cAMP phosphodiesterases, modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization","volume":"370","author":"Houslay","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2006.07.002_bib24","series-title":"Guide for the Care and Use of Laboratory Animals","author":"Institute of Laboratory Animal Research, Commission on Life Sciences, National Research Council","year":"1996"},{"key":"10.1016\/j.ejphar.2006.07.002_bib25","first-page":"274","article-title":"Comparison of piclamilast with ciclamilast in bronchodilating and antiallergic effects","volume":"32","author":"Ji","year":"2003","journal-title":"Zhejiang. Da. Xue. Xue. Bao. Yi. Xue. Ban."},{"key":"10.1016\/j.ejphar.2006.07.002_bib26","doi-asserted-by":"crossref","first-page":"7628","DOI":"10.1073\/pnas.122041599","article-title":"Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responses","volume":"99","author":"Jin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2006.07.002_bib27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1164\/ajrccm.163.1.2001118","article-title":"Inhibition of phosphodiesterase 4 attenuates airway hyperresponsiveness and airway inflammation in a model of secondary allergen challenge","volume":"163","author":"Kanehiro","year":"2001","journal-title":"Am. J. Respir. Medicine"},{"key":"10.1016\/j.ejphar.2006.07.002_bib28","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1046\/j.1365-2745.2002.01423.x","article-title":"Increased surfactant protein D (SP-D) in rat airway goblet and Clara cells during ovalbumin induced allergic airway inflammation","volume":"32","author":"Kasper","year":"2002","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.ejphar.2006.07.002_bib29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJM200101043440106","article-title":"Allergy and allergic diseases. First of two parts","volume":"344","author":"Kay","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2006.07.002_bib30","first-page":"72","article-title":"The role of the adrenergic system in allergy and bronchial hyperreactivity","volume":"121","author":"Koeter","year":"1982","journal-title":"Eur. J. Respir. Dis., Suppl."},{"key":"10.1016\/j.ejphar.2006.07.002_bib31","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nm734","article-title":"Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma","volume":"8","author":"Kuperman","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2006.07.002_bib32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/pupt.2000.0248","article-title":"A biochemical and functional assessment of monocyte phosphodiesterase activity in healthy and asthmatic subjects","volume":"13","author":"Landells","year":"2000","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2006.07.002_bib33","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/sj.bjp.0704120","article-title":"Identification and quantification of phosphodiesterase 4 subtypes in CD4 and CD8 lymphocytes from healthy and asthmatic subjects","volume":"133","author":"Landells","year":"2001","journal-title":"Br. J. Pharmacol."},{"issue":"9454","key":"10.1016\/j.ejphar.2006.07.002_bib34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0140-6736(05)17708-3","article-title":"Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease","volume":"365","author":"Lipworth","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2006.07.002_bib36","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/thx.2004.025692","article-title":"Phosphodiesterase 4 inhibition decreases MUC5AC expression induced by epidermal growth factor in human airway epithelial cells","volume":"60","author":"Mata","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.ejphar.2006.07.002_bib37","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2222.02193.x","article-title":"Therapeutic administration of budesonide ameliorates allergen-induced airway remodeling","volume":"35","author":"McMillan","year":"2005","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.ejphar.2006.07.002_bib38","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1096\/fj.03-0274com","article-title":"PDE4D plays a critical role in the control of airway smooth muscle contraction","volume":"17","author":"Mehats","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2006.07.002_bib39","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1165\/ajrcmb.17.6.2865","article-title":"Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis","volume":"17","author":"Minshall","year":"1997","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ejphar.2006.07.002_bib40","first-page":"201","article-title":"Leukocyte cyclic-3\u2032, 5\u2032-nucleotide phosphodiesterase activity in human bronchial asthma","volume":"37","author":"Mue","year":"1976","journal-title":"Ann. Allergy"},{"key":"10.1016\/j.ejphar.2006.07.002_bib41","unstructured":"National Institutes of Health, 2002. Global Initiative for Asthma: pocket guide for asthma management and prevention. Bethesda: National Institutes of Health, National Heart, Lung and Blood Institute; Publication no. 02-3659."},{"key":"10.1016\/j.ejphar.2006.07.002_bib42","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.1210\/jc.2002-020575","article-title":"Interleukin-1beta induces phosphodiesterase 4B2 expression in human myometrial cells through a prostaglandin E2- and cyclic adenosine 3\u2032,5\u2032-monophosphate-dependent pathway","volume":"87","author":"Oger","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2006.07.002_bib43","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pupt.2004.09.031","article-title":"The novel phosphodiesterase 4 inhibitor, CI-1044, inhibits LPS-induced TNF-alpha production in whole blood from COPD patients","volume":"18","author":"Ouagued","year":"2005","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2006.07.002_bib44","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1164\/rccm.2307005","article-title":"Airway hyperresponsiveness in asthma, geometry is not everything","volume":"168","author":"Pare","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2006.07.002_bib45","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0192-0561(88)90019-7","article-title":"Effects of ketotifen on the responsiveness of peripheral blood lymphocyte beta-adrenergic receptors","volume":"10","author":"Polson","year":"1988","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2006.07.002_bib46","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1046\/j.1365-2222.2001.01078.x","article-title":"Cytokine mRNA expression in patients with mild allergic asthma following low dose or cumulative dose allergen provocation","volume":"31","author":"Prieto","year":"2001","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.ejphar.2006.07.002_bib47","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S1357-4310(99)01635-4","article-title":"Eotaxin and eosinophil recruitment: implications for human disease","volume":"6","author":"Rankin","year":"2000","journal-title":"Mol. Med. Today"},{"key":"10.1016\/j.ejphar.2006.07.002_bib48","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1046\/j.1365-2745.2002.01474.x","article-title":"Airway goblet cell hyperplasia in asthma, hypersecretory and anti-inflammatory?","volume":"32","author":"Rogers","year":"2002","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.ejphar.2006.07.002_bib49","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.coph.2004.01.011","article-title":"Airway mucus hypersecretion in asthma, an undervalued pathology?","volume":"4","author":"Rogers","year":"2004","journal-title":"Curr. Opin. Pharmacol."},{"issue":"6 Pt 1","key":"10.1016\/j.ejphar.2006.07.002_bib50","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0091-6749(05)80144-7","article-title":"Alpha- and beta-adrenergic-receptor systems in bronchial asthma and in subjects without asthma, reduced mononuclear cell beta-receptors in bronchial asthma","volume":"86","author":"Sato","year":"1990","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2006.07.002_bib51","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1046\/j.1365-2133.1998.02223.x","article-title":"Cyclic adenosine monophosphate phosphodiesterase activity in peripheral blood mononuclear leucocytes from patients with atopic dermatitis, correlation with respiratory atopy","volume":"138","author":"Sawai","year":"1998","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejphar.2006.07.002_bib52","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1046\/j.1365-2559.2003.01664.x","article-title":"Asthma deaths, persistent and preventable mortality","volume":"43","author":"Sidebotham","year":"2003","journal-title":"Histopathology"},{"key":"10.1016\/j.ejphar.2006.07.002_bib53","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1164\/rccm.200211-1262OC","article-title":"Prenatal cigarette smoke decreases lung cAMP and increases airway hyperresponsiveness","volume":"168","author":"Singh","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2006.07.002_bib54","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.2165\/00003495-200363230-00002","article-title":"Phosphodiesterase-4 inhibitors in the treatment of inflammatory lung disease","volume":"63","author":"Spina","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2006.07.002_bib55","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1164\/rccm.200406-771OC","article-title":"Upregulation of phosphodiesterase-4 in the lung of allergic rats","volume":"171","author":"Tang","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2006.07.002_bib56","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1164\/ajrccm.157.2.9708012","article-title":"Phosphodiesterase isozymes, molecular targets for novel antiasthma agents","volume":"157","author":"Torphy","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2006.07.002_bib57","doi-asserted-by":"crossref","first-page":"L1120","DOI":"10.1152\/ajplung.2000.279.6.L1120","article-title":"Time course of inflammatory and remodeling events in a murine model of asthma, effect of steroid treatment","volume":"279","author":"Trifilieff","year":"2000","journal-title":"Am. J. Physiol., Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.ejphar.2006.07.002_bib59","first-page":"1859","article-title":"Behavior of the second messenger cAMP in status asthmaticus before and following administration of theophylline\u2013ethylenediamine","volume":"35","author":"Weth","year":"1985","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejphar.2006.07.002_bib60","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/abio.1994.1581","article-title":"Monitoring mRNA expression by polymerase chain reaction. The \u2018primer-dropping\u2019 methods","volume":"223","author":"Wong","year":"1994","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejphar.2006.07.002_bib61","first-page":"243","article-title":"Effects of cyclosporin A by aerosol on airway hyperresponsiveness and inflammation in guinea pigs","volume":"23","author":"Xie","year":"2002","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2006.07.002_bib62","first-page":"277","article-title":"Comparison of bronchodilating and antiinflammatory activities of oral formoterol and its (R,R)-enantiomers","volume":"24","author":"Xie","year":"2003","journal-title":"Acta Pharmacol. Sin."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429990600700X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429990600700X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T02:23:59Z","timestamp":1736475839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429990600700X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":59,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S001429990600700X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2006.07.002","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}